Natural products and Pharma 2011: strategic changes spur new opportunities. - Test2 - elhamkhani - TriplyDB

Natural products and Pharma 2011: strategic changes spur new opportunities.

Natural products and Pharma 2011: strategic changes spur new opportunities.

http://www.wikidata.org/entity/Q37930443

about

Capturing Biological Activity in Natural Product Fragments by Chemical Synthesis Anti-cancer effects of Gynostemma pentaphyllum (Thunb.) Makino (Jiaogulan)Bioactivity of fungal endophytes as a function of endophyte taxonomy and the taxonomy and distribution of their host plants Natural products as sources of new drugs over the 30 years from 1981 to 2010 Using functional signature ontology (FUSION) to identify mechanisms of action for natural products.Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance.Marketed marine natural products in the pharmaceutical and cosmeceutical industries: tips for success Marine actinobacteria associated with marine organisms and their potentials in producing pharmaceutical natural products.Chemical probes for the functionalization of polyketide intermediates.Antitumor Effects and Mechanism of Novel Emodin Rhamnoside Derivatives against Human Cancer Cells In Vitro Natural products as mediators of disease.Matching the power of high throughput screening to the chemical diversity of natural products Synthetic biological approaches to natural product biosynthesis.Synthetic strategies to terpene quinones/hydroquinones.Emerging trends in the discovery of natural product antibacterials.Industrial natural product chemistry for drug discovery and development.Natural product and natural product derived drugs in clinical trials.Uncovering the structures of modular polyketide synthases.Antibacterial products of marine organisms.Current Status and Future Prospects of Marine Natural Products (MNPs) as Antimicrobials.Scaffold Diversity Synthesis and Its Application in Probe and Drug Discovery.Populene D analogues: design, concise synthesis and antiproliferative activity.Total synthesis of (+)-trans-trikentrin A.Generate a bioactive natural product library by mining bacterial cytochrome P450 patterns.Antimicrobial activity of endophytic fungi from olive tree leaves.Biodiversity, drug discovery, and the future of global health: Introducing the biodiversity to biomedicine consortium, a call to action.Engineering fatty acid synthases for directed polyketide production.Asymmetric Construction of Pyrrolidines Bearing a Trifluoromethylated Quaternary Stereogenic Center via Cu(I) -Catalyzed 1,3-Dipolar Cycloaddition of Azomethine Ylides with β-CF3 -β,β-Disubstituted Nitroalkenes.Anti-Influenza A Viral Butenolide from sp. Smu03 Inhabiting the Intestine of Impact of Microbial Natural Products on Antibacterial Drug Discovery

P2860

Q26772873-A28E6BB8-76A8-4904-8F7A-3DBC7A04D333 Q28074630-5E9442E8-D226-477A-8CED-DA4353085562 Q28533477-716734E7-B09F-460A-AFDE-0E5C3510FC64 Q29616640-C6C4AE4B-F955-495A-9B1C-5A964BB94534 Q33822717-78FC9815-3967-42AB-A8C0-9F1B17FE3956 Q33834080-73A92DB5-DD77-4E16-A0FC-07FCD6609413 Q35096907-4D167299-50DE-447A-9543-103328DE64FE Q35213551-3A20AC95-21D7-43B4-A491-8E2E70A94345 Q35248736-B04DC935-DA0D-402C-BE0B-B3C43C67510C Q35872922-823B210C-A1D8-4801-8E09-A26B2F2F910C Q36200942-5F275DFD-E2CB-4570-BEDB-1848E02B587B Q37240957-8A411619-9B57-4F5A-9711-4AB770A1A1F7 Q37973514-751AE907-BAF5-4471-8C2E-C29F7B34FCB1 Q37993068-B13E717A-7ADF-41DB-840B-632471A5A163 Q38124531-CA8D3C74-FA76-472C-8F86-3061DE8D25FC Q38154186-F7232049-0488-493C-AE49-92A0F7874E7F Q38247457-7AA083AC-9673-44AC-91EA-4DF77CB13DAB Q38259700-26220897-BA77-4901-9EBB-F0025388DBC2 Q38421365-DCE40250-D810-405D-9646-C7A6D39A9D32 Q38636716-33DAC10C-BF29-4FB0-873C-FDDEB5C06B27 Q38836332-4FEF88A4-4AB5-4FA8-9A7A-E803446A68A6 Q39188290-A57F2F03-E462-45AA-9C7E-D8E2A4D0C4C2 Q39249722-B9727107-390F-4BFB-B4E4-AFA2557FB329 Q45269243-3B3720F9-A2E2-4412-A904-E32C1C267E61 Q46422044-655E90F3-3473-4B32-A3EA-BCD90EE0808B Q47146998-9E403805-5A4A-479C-8303-698851C5D4A7 Q50997208-41534717-8D40-4687-9926-ACD2D1BB26B9 Q51230882-F44052B2-67B8-4EDC-A920-B0A3EF094367 Q56989819-E2A4D96F-9065-47A3-BCDC-3A0519CB4BA2 Q57936466-ED5C557E-133E-4818-A0B3-C60B9EC71C2C

P2860

Natural products and Pharma 2011: strategic changes spur new opportunities.

http://www.wikidata.org/entity/Q37930443

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Natural products and Pharma 2011: strategic changes spur new opportunities.

@en

Natural products and Pharma 2011: strategic changes spur new opportunities.

@nl

type

label

Natural products and Pharma 2011: strategic changes spur new opportunities.

@en

Natural products and Pharma 2011: strategic changes spur new opportunities.

@nl

prefLabel

Natural products and Pharma 2011: strategic changes spur new opportunities.

@en

Natural products and Pharma 2011: strategic changes spur new opportunities.

@nl

P1433

Q37930443-EEC69B5B-14ED-4965-BD5E-3D44F55E7781

P1476

Q37930443-87B3984D-4B28-40FF-AA3A-1EDDEBF8666A

P2093

Q37930443-717E6E61-830C-409D-A6FD-FED4FDD7B26E

P2860

Q37930443-0639D8A5-3038-4FA1-A97E-338B6FAA587D

Q37930443-12DF23D6-D14E-41D4-9634-25D014AF1966

Q37930443-2168917A-5DBE-4BD5-BEA9-DF50D680F046

Q37930443-27B02632-18BE-43AD-A35B-B0A62DE40ADA

Q37930443-3994BA51-5B6F-4599-A8F5-76CC59B68AF2

Q37930443-3D87B3CC-A955-42EF-B770-B6CE536A97E4

Q37930443-43181879-3B31-4F30-B009-A25DD2A22601

Q37930443-47E4C6F0-5B59-405F-8876-294239B81122

Q37930443-49D20D17-6F6A-48B0-AB30-70F9A23F43F4

Q37930443-4F178E90-89CD-46AE-8E54-C33613B89859

P304

Q37930443-AF2A8AE5-D305-4D9A-BFF7-B83AB09D6F24

P31

Q37930443-2A40F9DF-F4DD-45DD-B418-1ECF92CD704A

P356

Q37930443-38061561-C3AD-479E-A1B2-B149D219131B

P433

Q37930443-7A912292-9066-4BEE-BC7F-DF3153CEE18B

P478

Q37930443-9A757E60-C410-43A2-9BE9-97724BF099D6

P577

Q37930443-1204A22B-1C5E-48F0-9386-7C49E1D0886F

P5875

Q37930443-A27E17B9-0812-400C-81F6-BE96FB27B42F

P698

Q37930443-D997CBD4-22CA-4444-A207-ED09CF36A457

P356

P1433

Natural Product Reports

P1476

Natural products and Pharma 2011: strategic changes spur new opportunities.

@en

P2093

Guy T Carter

http://www.w3.org/2001/XMLSchema#string

P2860

The discovery of salinosporamide K from the marine bacterium "Salinispora pacifica" by genome mining gives insight into pathway evolution

Polyketide synthase chemistry does not direct biosynthetic divergence between 9- and 10-membered enediynes

Optimizing natural products by biosynthetic engineering: discovery of nonquinone Hsp90 inhibitors

Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes

Network pharmacology: the next paradigm in drug discovery

Reaching for high-hanging fruit in drug discovery at protein-protein interfaces

Can the pharmaceutical industry reduce attrition rates?

Small-molecule inhibitors of protein-protein interactions: progressing towards the dream

Semi-synthetic DNA shuffling of aveC leads to improved industrial scale production of doramectin by Streptomyces avermitilis.

Pre-fractionated microbial samples--the second generation natural products library at Wyeth.

P304

1783-1789

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C1NP00033K

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51630358

http://www.w3.org/2001/XMLSchema#string

P698

21909580

http://www.w3.org/2001/XMLSchema#string